Advanced glycation end-products in corneas of patients with keratoconus

被引:9
|
作者
Dawczynski, J
Franke, S
Blum, M
Kasper, M
Stein, G
Strobel, J
机构
[1] Univ Jena, Dept Ophthalmol, D-07740 Jena, Germany
[2] Univ Jena, Dept Internal Med 4, D-6900 Jena, Germany
[3] Tech Univ Dresden, Inst Anat, D-8027 Dresden, Germany
关键词
D O I
10.1007/s00417-002-0445-3
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Keratoconus remains a poorly understood yet widespread disease which poses a potential threat to human vision. The underlying mechanisms are still not clear. One possible pathway is increased formation and accumulation of advanced glycation end-products (AGEs) in the cornea. Methods: Corneas obtained from six patients with keratoconus and from six healthy controls were investigated. An immunohistochemical localisation of the well-known AGE N-epsilon-carboxymethyllysine (CML) was performed using a polyclonal anti-CML antibody. Results: In the corneas of all six patients with keratoconus, CML immunoreactivity was found in the epithelial as well as in the endothelial cells. The keratocytes also showed a positive reaction. The controls, in contrast, showed very little or no immunoreactivity. Conclusion: In the epithelial, stromal and endothelial cells of corneas with keratoconus an accumulation of CML was detected which might play a role in the pathogenesis of keratoconus.
引用
收藏
页码:296 / 301
页数:6
相关论文
共 50 条
  • [1] Advanced glycation end-products in corneas of patients with keratoconus
    Jens Dawczynski
    Sibylle Franke
    Marcus Blum
    Michael Kasper
    Günter Stein
    Jürgen Strobel
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2002, 240 : 296 - 301
  • [2] Advanced glycation end products in corneas of patients with keratoconus.
    Dawczynski, J
    Franke, S
    Blum, M
    Kasper, M
    Stein, G
    Strobel, J
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S573 - S573
  • [3] Advanced glycation end-products and receptor for advanced glycation end-products expression in patients with idiopathic pulmonary fibrosis and NSIP
    Kyung, Sun Young
    Byun, Kyung Hee
    Yoon, Jin Young
    Kim, Yu Jin
    Lee, Sang Pyo
    Park, Jeong-Woong
    Lee, Bong Hee
    Park, Jong Sook
    Jang, An Soo
    Park, Choon Sik
    Jeong, Sung Hwan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (01): : 221 - 228
  • [4] Advanced glycation end-products: a review
    Singh, R
    Barden, A
    Mori, T
    Beilin, L
    DIABETOLOGIA, 2001, 44 (02) : 129 - 146
  • [5] Advanced glycation end-products and atherosclerosis
    Vlassara, H
    ANNALS OF MEDICINE, 1996, 28 (05) : 419 - 426
  • [6] The Chemistry of Advanced Glycation End-products
    Torres, Natalia M. P. de O.
    Xavier, Jadriane de A.
    Goulart, Marilia O. F.
    Alves, Rosemeire B.
    de Freitas, Rossimiriam P.
    REVISTA VIRTUAL DE QUIMICA, 2018, 10 (02) : 375 - 392
  • [7] Advanced glycation end-products: a review
    R. Singh
    A. Barden
    T. Mori
    L. Beilin
    Diabetologia, 2001, 44 : 129 - 146
  • [8] Advanced glycation end-products and the kidney
    Busch, Martin
    Franke, Sybille
    Ruester, Christiane
    Wolf, Gunter
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2010, 40 (08) : 742 - 755
  • [9] Advanced glycation end products in diabetic corneas
    Kaji, Y
    Usui, T
    Oshika, T
    Matsubara, M
    Yamashita, H
    Araie, M
    Murata, T
    Ishibashi, T
    Nagai, R
    Horiuchi, S
    Amano, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (02) : 362 - 368
  • [10] Osseous wound repair under inhibition of the axis of advanced glycation end-products and the advanced glycation end-products receptor
    Tsai, Sheng-Chueh
    Jheng, Yi-Han
    Wang, Chen-Ying
    Chen, Yi-Wen
    Lin, Yu-Fang
    Chen, Chih-Cheng
    Chang, Po-Chun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (10) : 973 - 980